Chemistry:Ferric derisomaltose

From HandWiki
Short description: Medication
Ferric derisomaltose
Clinical data
Trade namesMonoferric, Monofer
AHFS/Drugs.comMonograph
License data
Routes of
administration
Intravenous (IV)
ATC code
  • None
Legal status
Legal status
Identifiers
CAS Number
PubChem CID
DrugBank
UNII
KEGG
Chemical and physical data
FormulaC18H34FeO16+3
Molar mass562.299 g·mol−1
3D model (JSmol)

Ferric derisomaltose (FDI), sold under the brand name Monoferric among others, is a medication for the treatment of iron deficiency anemia (IDA) in adults who have intolerance to oral iron or have had unsatisfactory response to oral iron or who have non-hemodialysis dependent chronic kidney disease (NDD-CKD).[3] It was approved for use in the United States in January 2020.[3][4][5] It is given intravenously.[3]

References

External links